AI assistant
Sending…
ULTRALIFE CORP — Director's Dealing 2011
Jan 4, 2011
34105_dirs_2011-01-04_8f60bd51-2cf2-4b5c-9cdc-f67d4fa96e57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2010-12-30
Reporting Person: POPIELEC MICHAEL D (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-12-30 | Common Stock; $.10 par value | $6.4218 | M | 50000 | Acquired | 2017-12-30 | Common Stock; $.10 par value (50000) | Direct |
| 2011-01-03 | Common Stock; $.10 par value | $6.582 | M | 50000 | Acquired | 2017-12-30 | Common Stock; $.10 par value (50000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock; $.10 par value | 0 | Direct |
Footnotes
F1: This options vests as follows: 12,500 shares vest on 12/30/2011; 12,500 shares vests on 12/30/2012; 12,500 shares vest on 12/30/2013 and 12,500 shares vest on 12/30/2014.
F2: This options vests as follows: 12,500 shares vest on 12/30/2011; 12,500 shares vests on 12/30/2012; 12,500 shares vest on 12/30/2013 and 12,500 shares vest on 12/30/2014.
More from ULTRALIFE CORP
Proxy Solicitation & Information Statement
2026
Jun 2
Proxy Solicitation & Information Statement
2026
Jun 2
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 29
Annual Report
2026
Mar 23
Major Shareholding Notification
2026
Mar 17
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 10